10
Participants
Start Date
January 31, 2010
Primary Completion Date
June 30, 2012
Study Completion Date
June 30, 2012
Rituximab
intravenous (IV) Rituximab 1 gramX2, every (q) 2 weeks.
RECRUITING
Bullous diseases clinic, Department of dermatology, Rabin Medical Center, Petah Tikva
Collaborators (1)
Leumit Health Services
OTHER
Rabin Medical Center
OTHER